Tag : Orphan

Biology

IVERIC bio Enters into Strategic Manufacturing Relationship with Catalent’s Paragon Gene Therapy for Orphan Inherited Retinal Diseases

Newsemia
NEW YORK and SOMERSET, N.J. (PRWEB) June 17, 2019 IVERIC bio, Inc. (NASDAQ: ISEE) and Catalent Biologics, today announced that they have entered into an...
Latest News

Horizon Pharma plc Reports Record Fourth-Quarter and Full-Year 2018 Net Sales Driven by Orphan and Rheumatology Segment; Announces Full-Year 2019 Guidance

Newsemia
DUBLIN–(BUSINESS WIRE)–Horizon Pharma plc Reports Record 4Q18 and FY2018 Net Sales, Driven by Orphan and Rheumatology Segment; Announces Full-Year 2019 Guidance Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy